Signature Events

Signature Events 2017-09-12T09:48:33+00:00

Oregon Bio is pleased to offer programming to support the bioscience industry and our member companies. Below are highlighted signature events that we have offered in the past. For upcoming events, please visit our Upcoming Events page.

Diversity in the Workplace

July 20, 2017 at Genentech, Hillsboro, Oregon

More than 150 bio professionals, company leaders and students came to Genentech in Hillsboro on July 20 to talk about the impact of diversity in the workplace, ensuring more opportunities can be created for all Oregonians. The Diversity in The Workplace learning and professional development session began with an awareness-raising keynote by David Bangsberg, M.D., Founding Dean for the joint OHSU-PSU School of Public Health, who launched into his career inspired by hope and help for intravenous drug users. He said, “Where someone grows up determines more than just their schooling or their opportunities – it also affects their health and the health of their community.”

Following, Dr. Bangsberg joined panelists Leslie Garcia, Assistant Chief Diversity Officer and Assistant Vice Provost and Director, Center for Diversity and Inclusion at OHSU; Alex Glunz, Senior Production Manager at Genentech; and Lillian Lo, Interim Manager for Planning and Scheduling at Genentech. The diverse panel spoke of lessons learned both off and on the job as members of diverse populations across cultural, ethnic and gender communities. They spoke about key topic areas such as defining diversity, overcoming implicit and/or unconscious bias, the model that organizations can use to practice inclusion, and cultural responsiveness that can include the spectrum of the diverse workforce, including those with disabilities.

Afterward, attendees got firsthand opportunities to break out into smaller discussion groups with the panelists for more intimate and direct Q&A.

At the conclusion of the panel and breakout sessions, participants launched into one of Oregon Bio’s longtime traditions, Bio on the Vine.  The first ‘BOV’ was held a dozen years ago with about 40 attendees and one winery, which was owned by a local doctor!  But Oregon Bio has grown immensely over the years with this year’s showing of six wineries – Adelsheim, Angel Vine, CAW, Elk Cove Vineyards, Sineann and Tumwater Vineyard – and tastings from their 17 selections of our state’s wonderful bounty.

To track the pulse of the panel and the networking event, check in on Twitter – @OregonBio hashtags #diversityintheworkplace and #bioonthevine2017.

Day at the Capitol

April 27, 2017 at Oregon State Capitol, Salem, Oregon

On April 27, Oregon’s leading biotechnology and life science companies converged in Salem at the Oregon Capitol to bring innovation and advocacy front and center with our state’s lawmakers.

Legislators and their staffs, as well as dozens from the industry were able to connect among the many companies that brought demonstrations of their products and technologies. Firms came from around the state including Nemametrix and ThermoFisher from Eugene; Valliscor from Corvallis (see their tweet below); and Patheon and Lonza (formerly Capsugel/Bend Research) from Bend. Portland metro area organizations included DesignMedix, Elex Biotech, Jupiter Devices, Oregon Bioscience Incubator/OTRADI, Oregon Health & Science University, Recentia Health, UbiVac and Welch Allyn.

Also showcasing its new proposed biotechnology-focused building, Summit Development Group shared architectural renderings to spread the word about the new wet labs, development space and creative offices soon to be realized in Portland’s Innovation Quadrant at 808 S.E. Alder Street.

The outreach to state legislators was well timed and integrated with several pieces of proposed legislation that may have significant impacts on the industry. Following the morning session at the Capitol, Oregon Bio hosted the 21st Century Cures event at the Salem Convention Center.

Economic Impact Study Release Event

Strategy Briefing: Bioscience Innovation and Economic Impact in Oregon

May 3, 2015 at OMSI, Portland, Oregon

The new economic impact study shows bioscience in Oregon generates high-paying jobs, while bringing new money to the state through domestic and international exports. In 2014, the direct economic activity associated with Oregon’s bioscience industry includes:

  • 17,874 jobs and $1.3 billion in total wages,
  • An average annual wage of $74,188, which is 62 percent greater than the statewide average wage for private sector employment,
  • $3.8 billion in exports, and
  • $171.5 million in state and local taxes paid by bioscience firms and their employees.

Speakers:

  • Congresswoman Suzanne Bonamici (D – 1st District)
  • Congressman Kurt Schrader (D – 5th District)
  • Gary Locke, Fmr. U.S. Ambassador to China, U.S. Secretary of Commerce and Washington State Governor
  • Denise McCarty, Executive Director, Oregon Bio
  • Andrew Barofsky, CEO/President, RevMedx

Read the press release and Economic Impact Report.

Oregon Bio 2014: An Industry Inflection Point

September 15-17, 2014 at Marylhurst University, Marylhurst, Oregon

Oregon has long been a strong regional center of life science activity. The momentum and international attention of the $1 Billion OHSU Knight Cancer Challenge has created a “transformative moment” that will dramatically impact bioscience in the state – potentially enhancing commercialization opportunities, increasing resources available for research activity and elevating the visibility of all stakeholders working to solidify Oregon’s growing reputation as a hub for advanced medical research and commercialization.

Oregon Bio 2014 showcased the efforts of entrepreneurs and researchers responding to this opportunity in ways that reveal a growing statewide capacity and competency that is often invisible to those outside the industry. Conference speakers profiled academic, policy and industry driven initiatives that have successfully supported innovation and job creation. Oregon Bio 2014 celebrated the recent achievements throughout our state, explored opportunities that inspire life sciences professionals and offered potential solutions to the capital formation and professional/workforce training challenges our industry faces. Read more about Oregon Bio 2014.

Seeking 21st Century Cures

April 27, 2017 at Salem Convention Center, Salem, Oregon

Crucial conversations are underway across the country and world in board rooms, classrooms, universities, labs and researcher meetings in efforts to capture the myriad benefits and capitalize on the opportunities afforded by the 21st Century Cures Act.  The ‘Cures’ Act, signed into law in December 2016, is designed to accelerate the discovery, development, and delivery of present and future cures and authorizes $6.3 billion in funding, mostly for the National Institutes of Health.

Following the Day at the Capitol, Carol Pratt Ph.D., J.D., Partner and Regulatory Attorney with Lee & Hayes, presented at Oregon Bio’s 21st Century Cures in Oregon event, explaining how the Act will impact the practice and research around precision medicine. She particularly focused on the ongoing collaborations among federal agencies, the import and facilitation of Big Data and the new regulatory and legal requirements of how new policies will be needed to secure and protect data.

Bryce Olson, cancer patient and Global Marketing Director of Health and Life Sciences at Intel keynoted the event, detailing his personal health journey and how he pushed his oncologist to sequence his genes to obtain entry in a targeted clinical trial that had amazing results. Bryce proudly wears a t-shirt that proclaims, “Sequence Me!”

Chris Edwards, Assistant Vice President for Strategic Initiatives at the University of Oregon, also spoke at the event sharing his work on how the new $500 million contribution by Nike’s founder to the university has culminated in the $1 billion fundraising efforts for the Phil and Penny Knight Campus for Accelerating Scientific Impact.

With over 100 participants, the event spurred active conversations and networking at the following Bio in the Valley event. Thanks to sponsors of the 21 Century Cures event, Biotechnology Innovation Organization and Genentech, for their generous support.

Oregon Bio 2016: The Bioscience Landscape

October 20-21, 2016 at Reed College, Portland, Oregon

From a panel of futurists to rockstar entrepreneurs and scientists, Oregon Bio welcomed more than 300 attendees to its signature annual conference. The Company Pitch Showcase and Research Fast Pitch, both held on the first day of the conference, highlighted exciting startups and research scientists from Oregon. Attendees were also able to visit research posters presented by Oregon State University students and delve into the range of professional development and translational research/tech transfer topics during breakout sessions. Day one ended with an awards ceremony and jam session with blues band, Holfar Blue.

The second day of the conference highlighted innovation and collaboration with other sectors, from innovation strategy at Columbia Sportswear to the future of precision medicine at Intel Life Sciences. Attendees also heard from expert speakers on diversity topics, including generational differences and unconscious bias, and on developing bioscience throughout Oregon. Throughout the day, 26 exhibitors from Oregon and throughout the U.S. interacted and networked with conference attendees. The second day of Oregon Bio programming closed with a keynote highlighting bioscience legislation and remarks and Q&A with U.S. Senator, Ron Wyden. Read more about Oregon Bio 2016.

Beyond the Microscope: Examining Policies to Grow the Life Sciences Industry in Oregon

August 11, 2015 at The Nines Hotel, Portland, Oregon

At this important  summit led by industry leaders from Portland, Bend and Corvallis, we reviewed policies to support and cultivate the life sciences sector in Oregon. More information about the three panel discussions are below. Read more about Oregon Bio Policy or check out our infographic about the bioscience sector.

Translating Research to Industry

  • Moderator: Erin Flynn, Ph.D., PSU
  • Brendan Rauw, OHSU
  • Karl Mundorff, OSU Advantage Accelerator
  • Shula Jaron, Ph.D., FertiLab Thinkubator
  • Linda Hansen, Ph.D., Providence Health & Services

Growing Bioscience Companies in Oregon

  • Moderator: Ryan Dunlap, MolecularMD
  • Bernard Fox, Ph.D., UbiVac
  • Andrew Barofsky, RevMedx
  • Lisa Dzubay, Grace Bio-Labs
  • Matt Beaudet, NemaMetrix

Sustaining and Expanding Bioscience Companies in Oregon

  • Moderator: Jennifer Fox, Ph.D., OTRADI
  • Matt Smits, Biotronik/MSEI
  • Ken Betschart, Genentech
  • Kyle Gee, ThermoFisher Scientific
  • Soundharya Nagasubramanian, Welch Allyn

Oregon Bio 2015: Expanding the Ecosystem

September 9-10, 2015 in Portland, Oregon

As Oregonians we are rightly proud of our quality of life, however, our bioscience ecosystem has been a work in progress. In the areas of manufacturing supply chain, educated workforce, and research and development, Oregon has been traditionally strong. Now it is time to leverage our current industry momentum to make permanent and lasting improvements to this bioscience ecosystem.

Oregon Bio 2015 highlighted the innovative perspectives of nationally respected researchers, innovators and investors while highlighting the opportunities found in Oregon’s research and entrepreneurial sectors. To compete with the world’s best entrepreneurial ecosystems, Oregon must learn to cultivate innovation and reward the risks these pioneers take. Read more about Oregon Bio 2015.

Oregon Bio 2013: The Economics of Life Sciences

September 16-18, 2013 at Marylhurst University, Marylhurst, Oregon

Once again, Oregon’s bioscience community gathered to learn from national experts how to adapt to the trends driving the economics of our industry. This unique two- day conference exposed attendees to the strategies, resources and experts executives need to successfully navigate our rapidly changing industry.  Read more about Oregon Bio 2013.